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The eﬃcacy of toltrazuril treatment was assessed in two experiments in Polish swine herds. Experiment 1 included a toltrazuril
treatment group, Group A (n = 410), and untreated control, Group B (n = 386). Time to sale in Group A was 108 days versus 120
days for Group B, with average body weights at sale of 114.2kg and 108.8kg, respectively (P<0.05). In experiment 2, the health
status and body weight gain of 238 piglets treated with toltrazuril (Group D) were compared to 235 untreated piglets (Group K).
A similar diﬀerence was observed in average body weights of slaughtered animals, being on average 104kg in Group D and 101kg
in Group K (P<0.01). Animals from Group D were slaughtered 5 days earlier than animals from Group K (day 166 versus day
171). Data from clinical trials suggest treatment of coccidiosis with toltrazuril oﬀering potential for improved animal welfare and
yields, however this has remained unproven in ﬁeld conditionsin large swine production facilities. The present study conﬁrms the
eﬃcacyof toltrazuril treatment when used in the ﬁeld andthe subsequent positive impact on timeto weaning, time to market, and
on weight gain at all time points.
1.Introduction
Diarrhoea remains a signiﬁcant, though often underappre-
ciated, issue in both economic and welfare terms on many
swine farms worldwide. The most common cause of severe
diarrhoea in pigs aged 5–20 days is coccidiosis, caused by
infection by the near ubiquitous Eimeriidae coccidium
Isospora suis [1–3], which has been found in over 75%
of farms examined in Ireland, Germany, the Netherlands,
Greece, Austria, and Switzerland [4, 5]. A recent study into
I. suis prevalence in Poland found that 90% of farms tested
positive [4].
The I. suis parasite lifecycle has prepatent and patent
phases; the prepatent usually lasts 5–7 days, and the patent
lasts 5–16 days. Along with the characteristic 5–8 days of
creamy yellow diarrhoea, serious damage to the mucosal
cryptsand villiofsucklingpigletsduetoI.suis has previously
been reported [1, 3]. The rupture of cells of the villi of gut
mucosa during infection causes ﬁbrinous enteritis and long-
term damage to the gut, leaving piglets more susceptible to
other infections, such as E. coli and Clostridium perfringens
[7, 8]. Maturity of mucosa villous at weaning is of special
importance in terms of postweaning feeding performance
[9, 10]. Damage to the gut can also have a signiﬁcant impact
on the long-term growth and wellbeing of the piglet, causing
decreases in weight at weaning ofasmuch as 1kg[6],evenin
asymptomatic pigs [11].
As I. suis infection is spread through faecal matter, hy-
gieneisakeycomponentofcoccidiosisprevention.Intheory,
clearing farrowing pens and a programme of thorough,2 The Scientiﬁc World Journal
ongoing cleansing with an eﬀective oocysticide may to some
extent control the reappearance of coccidiosis, butnot totally
[12]. However, as I. suis infection is so prevalent, this is, in
practice, not eﬀective strategy.
Treatment with sulphonamides and diclazuril in exper-
imental studies has not proven eﬀective in managing coc-
cidiosis, but treatment simplicity and eﬃcacy were recently
signiﬁcantly improved by the approval of toltrazuril (Baycox
5%, Bayer Animal Health) for the treatment of coccidiosis
in swine. Individual treatment of piglets around day 4 of life
with 0.4mL/kg toltrazuril has provento be the most eﬀective
treatment option available [5, 6].
A number of studies have reported that treatment with
toltrazuril can improve the health of the gut and increased
weight gain [6, 8, 11], reduce use of antibiotics [13]a n dr a t e
of diarrhoea in early life [8], and improve postweaning feed
conversion ratios [9, 10].
The present study sets out to investigate the eﬃcacy of
toltrazuril treatment in swine herds in ﬁeld conditions in
Poland to ascertain whether the eﬃcacy reported in clinical
studies can be replicated in the ﬁeld, particularly in relation
to increased weight gain, reduced need for veterinary inter-
vention and faster time to market.
2.Materialsand Methods
2.1. Experiment 1. The therapeutic eﬃcacy of a single oral
treatmentwithtoltrazuril(Baycox5%,BayerAnimal Health)
(0.4mL/kg BW, equivalent to 20mg toltrazuril/kg BW) was
examined on two pig farms in Lower Silesia and Mazowia
voividships, Poland.
Farm 1 operated a closed, continuous ﬂow with all-in-
all-out (AIAO) system of production cycle with a basic herd
of 130 hybrid Polish Landrace x Polish Large White sows.
Study groups comprising 10 sows were created twice a week
during the study period. All welfare conditions in the labour
sectionsas well asin the breeding and fattening sections were
satisfactory. A history of I. suis infection was conﬁrmed on
Farm 1.
Farm 2 also operated a closed, continuous ﬂow with
AIAO system of production cycle, with a basic herd of 450
hybrid PIC sows. Study groups of 20 sows were created once
a week during the study period. All welfare conditions in
the labour sections as well as in the breeding and fattening
sections were satisfactory. All weaning piglets were sold on.
Ah i s t o r yo fI. Suis infection was conﬁrmed on Farm 2.
The study was conducted on 383 pigs from Farm 1 and
on413pigs fromFarm2based on simple randomisation. On
both farms, the group treated with toltrazuril was labelled
Group A (Farm 1, n = 205; Farm 2, n = 205) and the
nontreatedcontrolgroupasGroupB(Farm1,n = 178;Farm
2, n = 208) (Figure 1). Selection criteria were based on the
age of piglets and number of piglets in the litter.
Treatment eﬃcacy assessment was based on weight gain
from day 4 (ﬁrst day of toltrazuril administration) through
to day 14—deﬁned as the ﬁrst stage preweaning period—
and from day 14 to the day of weaning—the second stage
preweaning period.Pigletswere weaned when28and25days
Farm 1 (n = 383)
Farm 2 (n = 413)
Group A: toltrazuril (0.4 mL/kg) n = 205
Group A: toltrazuril (0.4 mL/kg) n = 205
Group B: control n = 178
Group B: control n = 208
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Figure 1: Experiment 1: Study design.
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Figure 2: Experiment 2: Study design.
old on farm 1 and 2, respectively. In addition, the frequency
of medical interventions (mainly antibiotic injections) re-
quired for diarrhoea control was measured. Prior to treat-
ment with toltrazuril, the presence of I. suis infection was
conﬁrmed by parasitological examination of 10% of piglet
faeces in all experimental groups. Oocysts were conﬁrmed in
all collected samples.
2.2. Experiment 2. The second experiment was carried out
on a production facility in Mazovia viovodship, Poland with
a closed, AIAO production cycle and a basic herd of 1,700
hybrid PIC sows and 10 hybrid Polish Landrace x Polish
Large White boars. Study groups comprising 90 sows were
created once a week during the production cycle. All welfare
conditions in the labour sections as well as in the breeding
and fattening sections were satisfactory.
The study evaluated the health status and body weight
gain of 238 piglets treated with a single dose of toltrazuril
(0.4mL/kg BW, equivalent to 20mg toltrazuril/kg BW)
(Group D) at day 4 of life compared to 235 untreated piglets
in the control group (Group K) (Figure 2) .T h ec h o i c eo ft h e
piglets was conducted as in experiment 1.The Scientiﬁc World Journal 3
Table 1: Experiment 1: Mean piglet body weight.
Piglet body weight
Day 4 Day 14 Day 28 Day 63 Day 108 Day 120
Farm 1 Group A 2093g ±390 4163g∗ ±854 7745g ± 1843 21300g∗±1351 114200g∗±3856 —
Group B 2125g ±420 3602g ± 571 6333g ± 933 20500g ±1381 — 108800g ±3036
Farm 2 Group A 2065g ±413 3910g∗ ± 879 6490g∗ ±1337 — — —
Group B 2062g ±374 3040g ±440 5385g ± 1118 — — —
∗P<0.05.
Table 2: Experiment 2: Mean piglet body weight.
Piglet body weight
Day 4 Day 25a/28b Day 52 Day 166 Day 171
Group D 1530g ± 103 6180g∗ ±271 31000g∗ ±1068 104000g∗ ± 7026 —
Group K 1540g ±97 5830g ±245 27900g ±1407 — 101000g ±7251
∗P<0.01.
aDay of weaned piglets in group D.
bDay of weaned piglets in group K.
Assessments of health status and body weight gain were
made on the 4th day of life (start of treatment), on the day
of weaning, when moving from the breeding sector to the
fattening sector, and ﬁnally on the day of sale.
Statistical calculations in both experiments were carried
out with Mann-Whitney U test and χ2 (chi-squared) test
with the use of Statistica v. 6.1 software.
3.Results
3.1. Experiment 1. Body weight gain of the piglets in Group
A (treatment group), between day 4 and day 14, was 2070g
and 1845g in Farms 1 and 2, respectively. Additional body
weight gain in Farms 1 and 2 in the second phase of weaning
(day 14 to weaning) was 3582g and 2580g, respectively.
Piglets in Group B (control group) gained 1477g on
Farm 1 and 978g on Farm 2 between day 4 and 14, and
additional 2737g and 2345g, respectively, between day 14
and weaning.
In the time to weaning, piglets in Group A required 6
medical interventions in both Farms 1 and 2, compared to
13 and 18 in Farms 1 and 2, respectively, for those in Group
B.
Piglets on Farm 1 were also followed through to sale to
ascertain the impact of treatment on long-term growth. At
transfer from weaning to a feeding group at day 63, average
body weight was 21300g for Group A versus 20500g in
Group B. Time to sale in Group A was 108 days for Group
A versus 120 days for Group B, with average body weights
at sale of 114200g and 108800g (P<0.05), respectively
(Table 1).
3.2. Experiment 2. Piglets in experiment 2 of the study were
assessed at days 4, 25, 52, 166, and 171. Those piglets in
treatment group D (n = 238 at birth, n = 210 at weaning)
weaned on average at 25.6 days, while those in the control
group K (n = 235 at birth, n = 194 at weaning) weaned on
average at 28 days.
There was a statistically signiﬁcant diﬀerence (P = 0.03)
in relation to average daily weight gain between Group D
(221g) and Group K (204g) at day 25, and a statistically
signiﬁcant diﬀerence was also observed between Groups D
and K in relation to reports of diarrhoea prior to weaning—
4 versus 22 cases, respectively (P<0.01). Body weight at
weaning and cases of digestive disorders or death showed no
statistical diﬀerence between groups.
After moving animals to the breeding sector on day 25,
averagebody weight oftheanimals inthegroupreceiving the
toltrazuril was 6180g and was greater than the body weight
of the piglets in Group K (P<0.01). After weaning, animals
were kept in their groups for fattening until day 52. Average
body weight of animals transferred to the fattening sector
was 31000g and 27900g, respectively, for Groups D and K.
A similar diﬀerence was observed in average body weights of
slaughtered animals, being on average 104000g in Group D
and 101000g in Group K (Table 2). Animals from Group D
were slaughtered 5 days earlier than animals from Group K
(day 166 versus day 171).
4.Discussion
Alongside the obvious short-term impact of diarrhoeal
disease, coccidiosis infection is responsible for signiﬁcant
damage to the gut of piglets, regardless of whether or not
they are symptomatic. This damage can have serious long-
term eﬀectsontheirhealth andgrowth,leading tosigniﬁcant
losses for the pig producer.
A number of experimental trials have demonstrated the
impact of toltrazuril on key production criteria including
daily weight gain, where treatment-related increases in
weight gain have been recorded at 37g/day to day 28 [6],
25g/day to weaning [11], and 14g/day between days 21 and
105 [9], and toltrazuril treatment-related feed conversion
rates in weaner-ﬁnisher herds of 2.41 versus 2.63 [10]a n d
1 . 6v e r s u s1 . 7 7[ 9]. Treatment with toltrazuril has also been4 The Scientiﬁc World Journal
shown to increase body weight at weaning by 670g (P<
0.05) [6] and 326.6g (P = 0.044) [8] compared to placebo.
While not directly investigating daily weight gains or
feed conversion rates, the present study has conﬁrmed the
signiﬁcant improvements in yield suggested by trial results
are indeed replicable in the “real world”, with treatment-
relatedweight gain of1412gand350gatweaning and5400g
and 3000g, respectively, for experiments 1 and 2 at time to
market. It was also notable that all treatment groups reached
weaning (3 days)and market weight (between 5 and 12 days)
substantially earlier than the untreated controls.
Cases of diarrhoea were also signiﬁcantly reduced in
treated groups, reﬂecting the previously reported ﬁndings
of McOrist and others [9] and Westphal and others [8].
The absence of signiﬁcant reductions in cases of digestive
disorders and death among groups in this study is likely to
reﬂect the already low mortality associated with coccidiosis
infection along with the multiplicity of infections (Porcine
Respiratory Disease Complex) aﬀecting piglets during the
weaning phase in a commercial swine production facility.
The results of this study, performed in ﬁeld conditions,
suggest that the use of a single application of toltrazuril is
likelyto produceresultssimilar to those noted inexperimen-
tal trials. These results support the view that, in real-world
conditions, metaphylaxis with toltrazuril is extremely eﬀec-
tive at managing the impact of I. suis infection on the health
and growth of piglets, leading to substantial improvements
in weight gain that continue over the lifetime of the pig,
bringing pigs to market weight substantially faster and at a
greater weight.
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